Zobrazeno 1 - 10
of 56
pro vyhledávání: '"M. Maset"'
Publikováno v:
Reumatismo, Vol 71, Iss 1 (2019)
Acquired haemophilia A (AHA) is a rare bleeding disorder due to autoantibodies directed against coagulation factor VIII. The treatment is based on recombinant activated factor VII and activated prothrombin complex concentrate. However, mainly in olde
Externí odkaz:
https://doaj.org/article/28d58df58f9f41139745f1cd49116431
Autor:
M. Maset, E. Mansutti, M. Fabris, S. Lombardi, M. Saracco, S. Salvin, L. Quartuccio, S. Pellerito, S. De Vita
Publikováno v:
Reumatismo, Vol 61, Iss 3, Pp 182-186 (2011)
Objective: Predictors of response to biologics in rheumatoid arthritis (RA) is an important issue in the current era. Rituximab (RTX) has been demonstrated effective and safe in active RA, resistant to traditional or biologic DMARDs. Methods: Fifty-s
Externí odkaz:
https://doaj.org/article/95ec3127d07c4a6abae84ea7c526b66b
Autor:
Endri Mauro, Pietro Casarin, A. Zanier, E. Garlatti Costa, Anna Ermacora, Michela Ghersetti, M. Maset
Publikováno v:
Reumatismo, Vol 71, Iss 1 (2019)
Acquired haemophilia A (AHA) is a rare bleeding disorder due to autoantibodies directed against coagulation factor VIII. The treatment is based on recombinant activated factor VII and activated prothrombin complex concentrate. However, mainly in olde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3a24ce3c3c016bbec64538cfb752c21
https://www.reumatismo.org/index.php/reuma/article/view/1041
https://www.reumatismo.org/index.php/reuma/article/view/1041
Autor:
Martina Fabris, M. Maset, Salvatore De Vita, Elena Pontarini, S. Salvin, Miriam Isola, Luca Quartuccio
Publikováno v:
Rheumatology. 52:276-281
OBJECTIVE Primary SS is characterized by an increased risk of lymphoma in patients with prelymphomatous manifestations (i.e. myoepithelial sialadenitis or mixed cryoglobulinaemia). Serum B-lymphocyte stimulator (s-BLyS) levels in SS-related B-cell ly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bdda4b82c8f1a61a5a70b4b4c4221ee
https://doi.org/10.1093/rheumatology/kes180
https://doi.org/10.1093/rheumatology/kes180
Autor:
Massimo Galli, Antonio Tavoni, Davide Filippini, Al Zignego, Patrizia Scaini, Stefano Bombardieri, Paola Masolini, Clodoveo Ferri, S. Migliaresi, Maria Teresa Mascia, M. Maset, Oreste Perrella, Mauro Campanini, C. Naclerio, M. Pietrogrande, Armando Gabrielli, Pietro Pioltelli, M. Lenzi, Alen Zabotti, S. De Vita, Miriam Isola, Dario Roccatello, Giuseppe Monti, Luca Quartuccio, Cesare Mazzaro
Publikováno v:
Arthritis & Rheumatism. 64:843-853
Objective To conduct a long-term, prospective, randomized controlled trial evaluating rituximab (RTX) therapy for severe mixed cryoglobulinemia or cryoglobulinemic vasculitis (CV). Methods Fifty-nine patients with CV and related skin ulcers, active g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1d3a0c81d4ed77c264c37cd023a7731
https://doi.org/10.1002/art.34331
https://doi.org/10.1002/art.34331
Autor:
S. Lombardi, E. Mansutti, S. Salvin, M. Maset, S. De Vita, M. Fabris, M. Saracco, Luca Quartuccio, S. Pellerito
Publikováno v:
Reumatismo, Vol 61, Iss 3, Pp 182-186 (2011)
Objective: Predictors of response to biologics in rheumatoid arthritis (RA) is an important issue in the current era. Rituximab (RTX) has been demonstrated effective and safe in active RA, resistant to traditional or biologic DMARDs. Methods: Fifty-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de84b1dc85da261ded77d39c89511f55
http://www.reumatismo.org/index.php/reuma/article/view/439
http://www.reumatismo.org/index.php/reuma/article/view/439
Publikováno v:
JCR: Journal of Clinical Rheumatology. 20:349-351
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370b8c79389609c1226821bd216ccfbd
https://doi.org/10.1097/rhu.0000000000000139
https://doi.org/10.1097/rhu.0000000000000139
Autor:
Stefano Bombardieri, Roberto Gerli, Francesco Carubbi, Roberta Priori, Vincenzo Della Mea, Miriam Isola, Elena Bartoloni Bocci, Chiara Baldini, Luca Quartuccio, Nicoletta Luciano, Ginevra De Marchi, Salvatore De Vita, S. Salvin, Guido Valesini, Roberto Giacomelli, Giorgia Gregoraci, M. Maset, Alessia Alunno, Serena Colafrancesco
Objectives To define the biomarkers associated with lymphoproliferation in primary Sjogren’s syndrome (pSS) by distinguishing in separate groups the two best-recognized non-malignant prelymphomatous conditions in pSS, i.e., salivary gland swelling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0af3495b3e850cbf0d9836c4599d1b
http://hdl.handle.net/11391/1209278
http://hdl.handle.net/11391/1209278
Autor:
Angelica Gattamelata, Serena Colafrancesco, Salvatore De Vita, Marialuisa Framarino-dei-Malatesta, Francesca Anna Letizia Strigini, M. Maset, M. Modesti, Marta Mosca, Chiara Baldini, Roberto Gerli, Alessia Alunno, Roberta Priori, Antonina Minniti, Elena Bartoloni, Chiara Tani, Luca Quartuccio, Stefano Bombardieri, Silvia Frisenda, Guido Valesini
Objective.To investigate pregnancy and fetal outcomes in patients with primary Sjögren syndrome (pSS).Methods.An obstetric history of 36 women with established diagnosis of pSS at pregnancy was obtained from a multicenter cohort of 1075 patients. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c55b9500ae1df6b06fbf6ee651fc32
http://hdl.handle.net/11391/1128468
http://hdl.handle.net/11391/1128468
Autor:
Martina Fabris, E. Mansutti, Giovanna De Maglio, Luca Quartuccio, Stefano Pizzolitto, Laura Mariuzzi, Carlo Alberto Beltrami, Elena Pontarini, Salvatore De Vita, M. Maset
Publikováno v:
Rheumatology (Oxford, England). 51(9)
Glucocorticoid (GC)-related adverse events greatly contribute to the outcome in giant cell arteritis (GCA). CYC was investigated as a steroid-sparing agent in GCA.Nineteen patients treated with CYC were retrospectively analysed. CYC was administered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940a2dfccd1572837631ec6acc56f3a7
https://pubmed.ncbi.nlm.nih.gov/22627726
https://pubmed.ncbi.nlm.nih.gov/22627726